COPD: Page 6

Helping COPD patients get a better night’s sleep
Liraglutide could help lessen sleep apnea in patients with COPD and obesity.
April 16, 2026
Stethoscope on gray fabric with sleep quality checklist showing good sleep selected
Answering the call for COPD inhaler education
Telephone training helps patients with COPD perfect the use of inhalers.
April 16, 2026
Man in glasses video calling on smartphone with professional on screen in modern office with plants
A smart approach to frailty prediction in elderly COPD patients
Researchers have developed a nomogram that uses machine learning to screen for pre-frailty and frailty.
April 9, 2026
Elderly person holding a wooden cane with caregiver's hand on shoulder, showing compassionate support and care
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Rademikibart achieves positive results in phase 1 trials for COPD, asthma
The IV-administered drug showed improvements in airway lung function as early as 15 minutes after dosing.
April 9, 2026
Healthcare professional in white coat and gloves holding glass of water in medical clinic
Tozorakimab meets primary endpoint in COPD trials
The drug is the first IL-33-targeting biologic to score high marks in two phase 3 clinical trials.
April 2, 2026
3D glowing cyan antibody molecules floating on dark blue background
Wearable data may help predict patient engagement in remote COPD rehab
Research from the Mayo Clinic finds remotely collected sleep data may be a useful tool in managing patients with COPD.
April 2, 2026
Person wearing Apple Watch displaying heart rate of 62 BPM with health monitoring interface
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Clinical tool could help reduce COPD hospitalizations
New scoring system helps identify patients with COPD who are most likely to require hospital treatment.
March 26, 2026
Doctor in white coat writing on clipboard during patient consultation at medical office
Nonpharmacological breathlessness action plans for COPD
Survey finds plans can help avoid ambulance calls and hospitalization, but more research is needed.
March 26, 2026
Woman coughing into her hand while sitting indoors with concern on her face
GOLD, GLI align on airflow obstruction criteria
Joint statement aims to increase the use of spirometry to confirm the diagnosis of COPD.
March 19, 2026
Healthcare professional in white coat demonstrating inhaler technique to elderly patient in red shirt during medical consultation
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Sleep apnea aggravates muscle loss in people with COPD
A study suggests that the combination of the two disease states reduces strength and physical performance.
March 19, 2026
Person walking down institutional hallway with brick walls and fire safety equipment
Increased stroke risk linked to COPD in older adults
Study examined mortality trends and disparities in adults aged 55 and older with both COPD and stroke.
March 12, 2026
Female doctor in white coat shaking hands with senior patient in olive green shirt during medical consultation in clinic examination room.
COPD phenotypes highlight sociodemographic differences
The risk of severe COPD was higher among certain demographic groups compared with others.
March 12, 2026
Red stethoscope with colorful patient figurines arranged in a semi-circle on blue background
Previous Page
Page 6 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial